Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03706742 · ClinicalTrials.gov registry record · NA
STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 12,386
- Enrollment target
NCT03706742 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 12,386 participants.
The verdict
NCT03706742, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 12,386 participants
- Enrollment target
Study Summary
Aim 1: The investigators will conduct a randomized controlled trial comparing two strategies to promote HCV screening, follow-up testing, and treatment among baby-boomers (i.e. persons born between 1945-1965): inreach with electronic medical record alerts and provider education vs. combination of inreach and provider education plus mailed outreach and patient navigation. Aim 2: The investigators will evaluate patient navigation strategies to promote follow-up testing and treatment evaluation among non-baby boomer Parkland patients (i.e. born before 1945 or after 1965) who are either: a) HCV antibody positive but have not completed follow-up viral load testing or b) HCV viral load positive and who have not completed in-clinic treatment evaluation.
Interventions
- BEHAVIORAL Mailed outreach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,386 participants |
| Start Date | 2018-09-10 |
| Est. Completion | 2021-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03706742
The ClinicalTrials.gov registry entry for NCT03706742 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12,386 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mailed outreach is the first listed.
NCT03706742 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03706742 about?
NCT03706742 is a clinical study titled "STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention". Aim 1: The investigators will conduct a randomized controlled trial comparing two strategies to promote HCV screening, follow-up testing, and treatment among baby-boomers (i.e. persons born between 1945-1965): inreach with electronic medical record alerts and provider education vs. combination of in...
What is the current status of trial NCT03706742?
This trial is currently completed. It is a NA study. The enrollment target is 12,386 participants. The study started on 2018-09-10. Estimated completion is 2021-03-31.
What interventions are being tested in trial NCT03706742?
The interventions under investigation include: Mailed outreach (BEHAVIORAL).
Who is sponsoring clinical trial NCT03706742?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.